PEMBROLIZUMAB
Clinical trials for PEMBROLIZUMAB explained in plain language.
Never miss a new study
Get alerted when new PEMBROLIZUMAB trials appear
Sign up with your email to follow new studies for PEMBROLIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets rare sarcomas in early trial
Disease control Recruiting nowThis study tests whether two drugs, zanzalintinib and pembrolizumab, can help control advanced soft-tissue sarcoma that has spread. About 20 adults with specific sarcoma types will receive the combination. The main goal is to check safety and side effects.
Matched conditions: PEMBROLIZUMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:07 UTC
-
New hope for tough ovarian cancers: Triple-Drug attack enters testing
Disease control Recruiting nowThis study is testing whether a combination of three drugs can help control recurrent ovarian cancer. It will involve about 20 adults whose cancer has returned after initial treatment. The main goals are to see if the treatment shrinks tumors and to understand what side effects p…
Matched conditions: PEMBROLIZUMAB
Phase: PHASE2 • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC